Myomo, Inc.MYONYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-23.67%
↓ 402% below average
Average (39q)
7.84%
Historical baseline
Range
High:98.56%
Low:-53.52%
Volatility
1940.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -23.67% |
| Q2 2025 | 11.80% |
| Q1 2025 | 14.77% |
| Q4 2024 | 24.89% |
| Q3 2024 | 23.99% |
| Q2 2024 | 5.33% |
| Q1 2024 | 8.91% |
| Q4 2023 | 22.41% |
| Q3 2023 | 27.12% |
| Q2 2023 | 18.29% |
| Q1 2023 | -4.54% |
| Q4 2022 | -27.63% |
| Q3 2022 | 9.09% |
| Q2 2022 | -4.04% |
| Q1 2022 | -16.26% |
| Q4 2021 | 22.83% |
| Q3 2021 | 6.85% |
| Q2 2021 | 14.10% |
| Q1 2021 | 25.60% |
| Q4 2020 | 21.15% |
| Q3 2020 | -13.11% |
| Q2 2020 | -21.53% |
| Q1 2020 | -6.94% |
| Q4 2019 | 0.01% |
| Q3 2019 | 1.64% |
| Q2 2019 | 0.12% |
| Q1 2019 | 1.06% |
| Q4 2018 | 17.78% |
| Q3 2018 | -7.66% |
| Q2 2018 | 30.78% |
| Q1 2018 | 4.34% |
| Q4 2017 | 8.35% |
| Q3 2017 | -53.52% |
| Q2 2017 | 98.56% |
| Q1 2017 | -12.23% |
| Q4 2016 | 71.07% |
| Q3 2016 | -7.97% |
| Q2 2016 | 21.21% |
| Q1 2016 | 0.47% |
| Q4 2015 | 0.00% |